Document Detail


Pharmacogenetics in reproductive and perinatal medicine.
MedLine Citation:
PMID:  20017673     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The clinical application of pharmacogenetics has been well accepted by some medical specialties, but not all. The aim of this review is to discuss the current use of pharmacogenetics in reproductive and perinatal medicine and to highlight areas where pharmacogenetics may be able to help in the future to predict response to medicines in terms of efficacy and safety. This applies to drugs that are specific to pregnancy and reproduction, as well as drugs prescribed for the treatment of medical disorders in pregnancy. Our review points out the need for well-designed clinical studies on the efficacy and safety of medicines used in women of childbearing age in order to define the additional utility provided by pharmacogenetic testing.
Authors:
Ana Alfirevic; Zarko Alfirevic; Munir Pirmohamed
Related Documents :
7114063 - Quality circles as a management tool for hospital pharmacy.
8952613 - Serendipity or luck: stumbling on gingival crevicular fluid.
12782893 - A prescription for the rogue doctor: part ii ready, aim, fire.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Pharmacogenomics     Volume:  11     ISSN:  1744-8042     ISO Abbreviation:  Pharmacogenomics     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2009-12-18     Completed Date:  2010-03-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897350     Medline TA:  Pharmacogenomics     Country:  England    
Other Details:
Languages:  eng     Pagination:  65-79     Citation Subset:  IM    
Affiliation:
Department of Pharmacology & Therapeutics, Sherrington Building, Ashton Street, University of Liverpool, Liverpool, Merseyside, L69 3GE, UK. Ana.Alfirevic@liv.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Betamethasone / therapeutic use
Dexamethasone / therapeutic use
Female
Fetus / drug effects
Folic Acid / metabolism,  therapeutic use
Humans
Infant, Newborn
Lung / drug effects,  embryology
Ovary / drug effects
Perinatal Care*
Pharmacogenetics*
Pre-Eclampsia / drug therapy
Pregnancy / drug effects
Reproductive Medicine*
Tocolysis
Chemical
Reg. No./Substance:
378-44-9/Betamethasone; 50-02-2/Dexamethasone; 59-30-3/Folic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  TaqMan((R)) low-density arrays and analysis by artificial neuronal networks predict response to neoa...
Next Document:  Meaningful use of pharmacogenomics in health records: semantics should be made explicit.